Lee C H, Giurescu M E, Philpotts L E, Horvath L J, Tocino I
Department of Diagnostic Radiology, Yale University School of Medicine, New Haven, CT 06520, USA.
Radiology. 1997 May;203(2):329-34. doi: 10.1148/radiology.203.2.9114083.
To determine the clinical importance of unilateral enlargement of axillary or intramammary lymph nodes on otherwise normal mammograms.
Twenty-four patients (aged 33-76 years) with unilaterally enlarging lymph nodes on otherwise normal mammograms were identified in a review of mammographic reports from 1991 to 1995. Mammograms, medical history, follow-up findings, and biopsy results were reviewed.
The initial nodal size was 3-17 mm. The size increased by 20%-312%. Seven patients had a history of malignancy. Six patients had a clinical history suggestive of a benign cause of nodal enlargement. Seven patients underwent biopsy. Two patients had results positive for malignancy (one, melanoma; one, lymphoma). Both patients had a known history of malignancy and a size increase of greater than 100%. In 17 patients, mammographic follow-up findings at 6-58 months (mean, 26 months) showed decreased nodal size in 13 and no change in four patients.
Enlarging lymph nodes on otherwise normal mammograms are usually benign. Clinical history can reveal possible causes of nodal enlargement. If the patient has no history of malignancy, the amount of nodal size increase is small, and the node maintains a benign appearance, mammographic follow-up is a reasonable alternative to biopsy.
确定在其他方面正常的乳腺钼靶片上腋窝或乳腺内淋巴结单侧增大的临床意义。
在回顾1991年至1995年的乳腺钼靶报告时,识别出24例(年龄33 - 76岁)在其他方面正常的乳腺钼靶片上有单侧淋巴结增大的患者。对乳腺钼靶片、病史、随访结果和活检结果进行了回顾。
最初淋巴结大小为3 - 17毫米。大小增加了20% - 312%。7例患者有恶性肿瘤病史。6例患者的临床病史提示淋巴结增大为良性原因。7例患者接受了活检。2例患者活检结果为恶性(1例为黑色素瘤;1例为淋巴瘤)。这2例患者均有已知的恶性肿瘤病史且大小增加超过100%。17例患者在6 - 58个月(平均26个月)的乳腺钼靶随访结果显示,13例患者的淋巴结大小减小,4例患者无变化。
在其他方面正常的乳腺钼靶片上淋巴结增大通常为良性。临床病史可揭示淋巴结增大的可能原因。如果患者没有恶性肿瘤病史,淋巴结大小增加量小,且淋巴结保持良性表现,乳腺钼靶随访是活检的合理替代方法。